The economic value of a transplant nephrologist: The case for improving compensation models

IF 8.2 2区 医学 Q1 SURGERY American Journal of Transplantation Pub Date : 2025-06-01 Epub Date: 2025-03-15 DOI:10.1016/j.ajt.2025.03.011
Mehmet U.S. Ayvaci , Tracy Giacoma , Marwan S. Abouljoud , Bekir Tanriover
{"title":"The economic value of a transplant nephrologist: The case for improving compensation models","authors":"Mehmet U.S. Ayvaci ,&nbsp;Tracy Giacoma ,&nbsp;Marwan S. Abouljoud ,&nbsp;Bekir Tanriover","doi":"10.1016/j.ajt.2025.03.011","DOIUrl":null,"url":null,"abstract":"<div><div>This article examined the economic value of transplant nephrologists and the need for adequate compensation. Kidney transplantation is a health and lifespan-extending procedure that relies on the expertise of transplant nephrologists. However, current compensation models, primarily based on relative value units (RVUs), often fail to capture the full scope of their work, particularly nonbillable activities essential to patient care. Additionally, regulatory compliance issues, particularly those related to the physician self-referral law (also known as the Stark law), complicate compensation structures. The Stark law mandates that physician compensation must align with fair market value to avoid conflicts of interest, adding complexity to designing compensation packages that accurately reflect the value of transplant nephrologists’ contributions. This article critiques the RVU-based system, highlighting its limitations in adequately compensating these specialists and proposing solutions such as integrating customized RVUs and outcome value units to better account for nonbillable work and incentivize high-quality care. The use of Medicare organ acquisition cost reports is also suggested to align compensation more closely with the actual economic value generated. A comprehensive approach that addresses both the quantitative and qualitative aspects of transplant nephrologists’ work, while navigating regulatory requirements, is essential for adequate and equitable compensation.</div></div>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"25 6","pages":"Pages 1156-1162"},"PeriodicalIF":8.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1600613525001406","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

This article examined the economic value of transplant nephrologists and the need for adequate compensation. Kidney transplantation is a health and lifespan-extending procedure that relies on the expertise of transplant nephrologists. However, current compensation models, primarily based on relative value units (RVUs), often fail to capture the full scope of their work, particularly nonbillable activities essential to patient care. Additionally, regulatory compliance issues, particularly those related to the physician self-referral law (also known as the Stark law), complicate compensation structures. The Stark law mandates that physician compensation must align with fair market value to avoid conflicts of interest, adding complexity to designing compensation packages that accurately reflect the value of transplant nephrologists’ contributions. This article critiques the RVU-based system, highlighting its limitations in adequately compensating these specialists and proposing solutions such as integrating customized RVUs and outcome value units to better account for nonbillable work and incentivize high-quality care. The use of Medicare organ acquisition cost reports is also suggested to align compensation more closely with the actual economic value generated. A comprehensive approach that addresses both the quantitative and qualitative aspects of transplant nephrologists’ work, while navigating regulatory requirements, is essential for adequate and equitable compensation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
移植肾科医生的经济价值:改进补偿模式的理由。
本文探讨了肾移植医师的经济价值和适当补偿的必要性。肾移植是一项健康和延长寿命的手术,依赖于移植肾病学家的专业知识。然而,目前的薪酬模式,主要基于相对价值单位(RVUs),往往不能充分反映他们的工作范围,特别是对病人护理至关重要的非计费活动。此外,法规遵从性问题,特别是那些与医生自我推荐法(也称为斯塔克法)相关的问题,使薪酬结构复杂化。《斯塔克法》规定,医生的薪酬必须与公平的市场价值保持一致,以避免利益冲突,这增加了设计薪酬方案的复杂性,使其准确反映移植肾病学家的贡献价值。本文批评了基于rvu的系统,强调了其在充分补偿这些专家方面的局限性,并提出了解决方案,如整合定制rvu (crvu)和结果价值单位(ovu),以更好地解释非计费工作并激励高质量的护理。还建议使用医疗保险器官获取成本(OAC)报告,使补偿与实际产生的经济价值更紧密地结合起来。一个综合的方法,解决移植肾病学家的工作的定量和定性方面,同时导航监管要求,是必要的充分和公平的补偿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
18.70
自引率
4.50%
发文量
346
审稿时长
26 days
期刊介绍: The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide. The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.
期刊最新文献
Pre-Transplant Circulating cTfh17 and Donor-Reactive T Follicular Helper Responses Distinguish Liver Transplant Recipients Who Develop Ischemia-Reperfusion Injury and Donor-Specific Antibody. Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study. Does the Kidney allograft serve as an in-vivo flow cytometer? The answer, my friend, is flowin' in the urine (with apologies to Bob Dylan). Comment on "A new principle to attenuate ischemia-reperfusion injury in kidney transplantation". The Impact of Organ Blood Type Conversion on Kidney Paired Donation: A Simulation and Optimization Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1